Temporary nitinol implantation for the treatment of benign prostatic hyperplasia

Rathbone J, Ma N, Goetz G
Record ID 32018014481
English
Authors' objectives: Benign prostatic hyperplasia (BPH) affects the quality of life for many men. TIND is a temporary, minimally invasive nitinol implant for the relief of symptoms.
Authors' results and conclusions: The evidence (very low certainty) showed an improvement in symptoms but also a higher rate of adverse events. Due to the lack of comparisons with standard therapies and long-term data, an added benefit of TIND cannot currently be proven. Key limitations are the high risk of bias and the indirectness of the evidence.
Authors' methods: To evaluate the method, a systematic review was conducted, identifying one RCT (n=185) versus a sham procedure and one single-arm study.
Details
Project Status: Completed
URL for project: https://aihta.at/page/bewertung-medizinischer-einzelleistungen-mel-berichte/en
Year Published: 2025
URL for published report: https://eprints.aihta.at/1569/1/DSD_129_Update2025.pdf
URL for additional information: https://eprints.aihta.at/1569/
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Austria
MeSH Terms
  • Prostatic Hyperplasia
  • Minimally Invasive Surgical Procedures
  • Prostate
  • Prostheses and Implants
  • Nickel
  • Titanium
  • Prosthesis Implantation
  • Lower Urinary Tract Symptoms
Keywords
  • Benign Prostatic Hyperplasia
  • Temporary Implantable Nitinol Device
  • TIND
  • Lower Urinary Tract Symptoms
  • Minimally Invasive Surgical Therapy
Contact
Organisation Name: Austrian Institute for Health Technology Assessment
Contact Address: Josefstaedter Strasse 39, A-1080 Vienna, Austria
Contact Name: office@aihta.at
Contact Email: office@aihta.at
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.